The noncoding regulatory role of HMGB1 in HCC upregulates PD‐L1+ exosomes, which reduces apoptotic cells’ frequency and leads to tumor progression, and may explain treatment resistance and predict immunotherapy. This evidence concerns the gene HMGB1 and neoplasm.